Technology news and discussion on TalkFuse.
Your Period Tracker Is (Probably) Spying on You
A Mozilla Foundation audit in partnership with Harvard's Berkman Klein Center examined privacy practices across six popular period tracking applications and uncovered systematic data harvesting by commercial developers. The worst performer, Stardust, transmitted users' reproductive health records—including birth control methods, pregnancy status, and specific symptoms—to undisclosed third-party firms beginning at app launch before users entered any information. The application routed data through analytics platforms with no way for users to disable sharing and also connected user behaviour to Facebook's advertising profiles using persistent identifiers.
By contrast, Euki, a nonprofit-operated tracker, achieved perfect privacy marks by storing all health information exclusively on users' devices, requiring no account, and offering controls such as PIN protection and scheduled data deletion. The audit highlighted a fundamental divide in how reproductive health applications treat sensitive personal information, with most commercial services optimising for monetisation through data partnerships rather than user privacy. The findings raise questions about consent and the collection of intimate data by apps targeting women's health.
In short
- Mozilla audit of six period trackers found most share intimate reproductive health data with undisclosed analytics firms without clear user consent
- Stardust scored lowest (2/10) for transmitting personal details to third-party services from app launch; Euki nonprofit earned perfect score with local-only storage
- Study reveals commercial trackers prioritise data monetisation through analytics partnerships over user privacy protection
Steelman: both sides, in good faith
The strongest fair case each way — we don't pick a winner.
The case for
Reproductive health data is uniquely intimate and sensitive, potentially affecting employment, insurance, relationships, and safety. This audit demonstrates that commercial incentives systematically lead to privacy violations and inadequate consent even before users input any information. Advocates for strong privacy protection argue that access to essential health tools should not require surrendering fundamental privacy rights, and point to Euki as proof that better models exist. They contend that reproductive health data deserves legal treatment comparable to medical records, with strict limitations on third-party sharing to protect users' autonomy and prevent discrimination.
The case against
Supporters of market-based approaches argue that free applications require sustainable revenue models, and data-driven advertising is a standard practice enabling companies to serve users without subscription fees that would exclude lower-income women. They contend the solution is not prohibition but transparency and user choice—those prioritising privacy can use paid alternatives like Euki, whilst others accept data sharing in exchange for free access. They warn that heavy regulation could render free apps economically unviable, ultimately restricting access to health tools. They believe competition and clear disclosure will incentivise better privacy practices without requiring blanket prohibitions on data sharing.
Explained simply
Period tracking applications help users monitor their menstrual cycles and reproductive health. A new examination of these popular apps has found that many collect and share sensitive personal information with outside companies, raising concerns about privacy and how intimate data is handled.
The Mozilla Foundation and Harvard's Berkman Klein Center audited six popular period tracking apps and discovered significant differences in privacy practices. Some apps, such as Stardust, transmitted detailed health information including birth control methods and pregnancy status to undisclosed companies, whilst others, like the nonprofit Euki, stored all data exclusively on users' devices without sharing it.
The findings highlight a wider divide in how technology companies treat user information: some prioritise generating revenue through data sales and partnerships, whilst others prioritise user privacy. Reproductive health data is particularly sensitive, making questions about consent and data collection especially important.
AI Cybersecurity Entertainment Europe Music Technology World